Suppressive effects of obesity on NK cells: is it time to incorporate obesity as a clinical variable for NK cell-based cancer immunotherapy regimens?

J Immunother Cancer. 2024 Mar 13;12(3):e008443. doi: 10.1136/jitc-2023-008443.

Authors

Robert J Canter¹, Sean J Judge², Craig P Collins³, Daniel Jaeho Yoon³, William J Murphy⁴

Affiliations

¹ Surgery, UC Davis, Davis, California, USA.
² Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
³ Dermatology, University of California Davis, Davis, California, USA.
⁴ Dermatology, University of California Davis, Davis, California, USA [email protected].

No abstract available

Keywords: Clinical Trials as Topic; Immunotherapy; Killer Cells, Natural.

MeSH terms

Humans
Immunotherapy
Killer Cells, Natural*
Neoplasms* / therapy
Obesity / therapy